{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:17:23Z","timestamp":1780359443353,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12264-012-1238-2","type":"journal-article","created":{"date-parts":[[2012,5,20]],"date-time":"2012-05-20T08:53:59Z","timestamp":1337504039000},"page":"253-258","source":"Crossref","is-referenced-by-count":77,"title":["Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Xi-Xun","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Xia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"key":"1238_CR1","first-page":"239","volume":"32","author":"M.B. Youdim","year":"1990","unstructured":"Youdim MB, Ben-Shachar D, Riederer P. The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson\u2019s disease. J Neural Transm Suppl 1990, 32: 239\u2013248.","journal-title":"J Neural Transm Suppl"},{"key":"1238_CR2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuint.2007.03.006","volume":"51","author":"H. Jiang","year":"2007","unstructured":"Jiang H, Song N, Wang J, Ren LY, Xie JX. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem Int 2007, 51: 32\u201336.","journal-title":"Neurochem Int"},{"key":"1238_CR3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(03)00353-3","volume":"2","author":"Y. Ke","year":"2003","unstructured":"Ke Y, Ming Qian Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2003, 2: 246\u2013253.","journal-title":"Lancet Neurol"},{"key":"1238_CR4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1196\/annals.1306.025","volume":"1012","author":"M.B. Youdim","year":"2004","unstructured":"Youdim MB, Stephenson G, Ben Shachar D. Ironing iron out in Parkinson\u2019s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N Y Acad Sci 2004, 1012: 306\u2013325.","journal-title":"Ann N Y Acad Sci"},{"key":"1238_CR5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11064-007-9482-y","volume":"33","author":"I.G. Onyango","year":"2008","unstructured":"Onyango IG. Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Neurochem Res 2008, 33: 589\u2013597.","journal-title":"Neurochem Res"},{"key":"1238_CR6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jtemb.2008.03.010","volume":"22","author":"A.G. Sarafanov","year":"2008","unstructured":"Sarafanov AG, Todorov TI, Kajdacsy-Balla A, Gray MA, Macias V, Centeno JA. Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry. J Trace Elem Med Biol 2008, 22: 305\u2013314.","journal-title":"J Trace Elem Med Biol"},{"key":"1238_CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tips.2004.03.003","volume":"25","author":"W. Meissner","year":"2004","unstructured":"Meissner W, Hill MP, Tison F, Gross CE, Bezard E. Neuroprotective strategies for Parkinson\u2019s disease: conceptual limits of animal models and clinical trials. Trends Pharmacol Sci 2004, 25: 249\u2013253.","journal-title":"Trends Pharmacol Sci"},{"key":"1238_CR8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1749-6632.1999.tb08035.x","volume":"890","author":"W. Slikkker","year":"1999","unstructured":"Slikkker W, Youdim M, Palmer GC, Hall E, Williams C, Trembly B. The future of neuroprotection. Ann N Y Acad Sci 1999, 890: 529\u2013533.","journal-title":"Ann N Y Acad Sci"},{"key":"1238_CR9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0891-5849(94)90202-X","volume":"16","author":"Y. Hanasaki","year":"1994","unstructured":"Hanasaki Y, Ogawa S, Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 1994, 16: 845\u2013850.","journal-title":"Free Radic Biol Med"},{"key":"1238_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-2952(93)90371-3","volume":"45","author":"I. Morel","year":"1993","unstructured":"Morel I, Lescoat G, Cogrel P, Sergent O, Pasdeloup N, Brissot P, et al. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol 1993, 45: 13\u201319.","journal-title":"Biochem Pharmacol"},{"key":"1238_CR11","doi-asserted-by":"crossref","first-page":"e3508","DOI":"10.1371\/journal.pone.0003508","volume":"3","author":"T. Santel","year":"2008","unstructured":"Santel T, Pflug G, Hemdan NY, Schafer A, Hollenbach M, Buchold M, et al. Curcumin inhibits glyoxalase 1: a possible link to its antiinflammatory and anti-tumor activity. PLoS One 2008, 3: e3508.","journal-title":"PLoS One"},{"key":"1238_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/jf9805348","volume":"47","author":"T. Masuda","year":"1999","unstructured":"Masuda T, Hidaka K, Shinohara A, Maekawa T, Takeda Y, Yamaguchi H. Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin. J Agric Food Chem 1999, 47: 71\u201377.","journal-title":"J Agric Food Chem"},{"key":"1238_CR13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinorgbio.2003.10.014","volume":"98","author":"S. Daniel","year":"2004","unstructured":"Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. Through metal binding, curcumin protects against lead- and cadmiuminduced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 2004, 98: 266\u2013275.","journal-title":"J Inorg Biochem"},{"key":"1238_CR14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10495-006-6715-5","volume":"11","author":"J. Chen","year":"2006","unstructured":"Chen J, Tang XQ, Zhi JL, Cui Y, Yu HM, Tang EH, et al. Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ioninduced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 2006, 11: 943\u2013953.","journal-title":"Apoptosis"},{"key":"1238_CR15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bcp.2009.03.031","volume":"78","author":"J. Wang","year":"2009","unstructured":"Wang J, Du XX, Jiang H, Xie JX. Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 2009, 78: 178\u2013183.","journal-title":"Biochem Pharmacol"},{"key":"1238_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/cr.2010.20","volume":"20","author":"H. Jiang","year":"2010","unstructured":"Jiang H, Song N, Xu H, Zhang S, Wang J, Xie J. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE\/IRP dependent. Cell Res 2010, 20: 345\u2013356.","journal-title":"Cell Res"},{"key":"1238_CR17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/WNR.0b013e32821c51fe","volume":"18","author":"Z.G. Ma","year":"2007","unstructured":"Ma ZG, Wang J, Jiang H, Liu TW, Xie JX. Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. Neuroreport 2007, 18: 1181\u20131185.","journal-title":"Neuroreport"},{"key":"1238_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00702-010-0531-3","volume":"118","author":"D.T. Dexter","year":"2011","unstructured":"Dexter DT, Statton SA, Whitmore C, Freinbichler W, Weinberger P, Tipton KF, et al. Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson\u2019s disease after peripheral administration. J Neural Transm 2011, 118: 223\u2013231.","journal-title":"J Neural Transm"},{"key":"1238_CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2008.05.003","volume":"174","author":"T. Ak","year":"2008","unstructured":"Ak T, Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008, 174: 27\u201337.","journal-title":"Chem Biol Interact"},{"key":"1238_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1478-3231.2008.01793.x","volume":"29","author":"D.J. Messner","year":"2009","unstructured":"Messner DJ, Sivam G, Kowdley KV. Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells. Liver Int 2009, 29: 63\u201372.","journal-title":"Liver Int"},{"key":"1238_CR21","first-page":"179","volume":"109","author":"C.D. Earl","year":"1996","unstructured":"Earl CD, Reum T, Xie JX, Sautter J, Kupsch A, Oertel WH, et al. Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson\u2019s disease: in vivo voltammetric data. Exp Brain Res 1996, 109: 179\u2013184.","journal-title":"Exp Brain Res"},{"key":"1238_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuint.2008.10.003","volume":"54","author":"J. Wang","year":"2009","unstructured":"Wang J, Xu HM, Yang HD, Du XX, Jiang H, Xie JX. Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int 2009, 54: 43\u201348.","journal-title":"Neurochem Int"},{"key":"1238_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","volume":"65","author":"D. Blum","year":"2001","unstructured":"Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease. Prog Neurobiol 2001, 65: 135\u2013172.","journal-title":"Prog Neurobiol"},{"key":"1238_CR24","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","volume":"105","author":"J. Salazar","year":"2008","unstructured":"Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 2008, 105: 18578\u201318583.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1238_CR25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuint.2006.04.015","volume":"49","author":"H. Jiang","year":"2006","unstructured":"Jiang H, Luan Z, Wang J, Xie J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 2006, 49: 605\u2013609.","journal-title":"Neurochem Int"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-012-1238-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-012-1238-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-012-1238-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:55:53Z","timestamp":1559444153000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-012-1238-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1007\/s12264-012-1238-2","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}